Related Experiment Videos
Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers
Naoki Hattori1, Takashi Ishihara, Yasuhiko Saiki
1Department of Pharmacology, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu-city, Shiga, Japan. hattorin@fc.ritsumei.ac.jp
Objective:
Macroprolactinaemia is one of the causes of hyperprolactinaemia and often leads to misdiagnosis and inappropriate treatment, but the aetiologies are unclear. The objective of the study was to determine the prevalence of macroprolactinaemia in a healthy population and to investigate the mechanisms underlying the development of macroprolactin.
Design:
Observational study of the prevalence, causes, mechanisms and diagnosis of disease using excess sera after hepatitis B virus screening tests at a hospital in Japan.
Participants:
A total of 1330 hospital workers (1010 women and 320 men) participated in this study.
Measurements:
Macroprolactinaemia was screened using the polyethylene glycol (PEG) precipitation method. Sera containing macroprolactin were further examined by binding studies for possible aetiologies.
Results:
Of the 1330 subjects, 49 (3.68%) were diagnosed with macroprolactinaemia. The frequency of hyperprolactinaemia in untreated samples in subjects with macroprolactinaemia (30.6%) was significantly higher than in individuals without macroprolactinaemia (2.26%). Of the 49 subjects with macroprolactinaemia, all had a normal monomeric PRL concentration following PEG removal of macroprolactin. Of 44 hyperprolactinaemias found, 15 (34.1%) had macroprolactinaemia. IgG-bound prolactin was detected in all sera containing macroprolactin. The levels of IgG-bound prolactin positively correlated with those of macroprolactin, suggesting that IgG-bound prolactin forms macroprolactin. Approximately three quarters of the subjects with macroprolactinaemia had anti-prolactin autoantibodies. Glycosylation, aggregation and covalent/noncovalent binding were also involved in the formation of macroprolactin.
Conclusions:
Macroprolactinaemia is a common disorder and causes hyperprolactinaemia in a healthy population. The major aetiology of macroprolactin in our subjects was complexes of prolactin-IgG comprising mainly anti-prolactin autoantibodies, and other minor complex prolactin species.
Insights
Macroprolactinaemia, a common cause of hyperprolactinaemia, is often misdiagnosed. This study found prolactin-IgG complexes, mainly from autoantibodies, are the primary cause in healthy individuals.
Area of Science:
- Endocrinology
- Clinical Chemistry
Background:
- Macroprolactinaemia is a significant cause of hyperprolactinaemia, frequently leading to misdiagnosis and inappropriate treatment.
- The underlying aetiologies of macroprolactinaemia remain unclear, necessitating further investigation.
Purpose of the Study:
- To determine the prevalence of macroprolactinaemia in a healthy population.
- To investigate the mechanisms responsible for the development of macroprolactin.
Main Methods:
- An observational study was conducted using excess sera from hospital workers in Japan.
- Macroprolactinaemia screening was performed using the polyethylene glycol (PEG) precipitation method.
- Binding studies were employed to examine sera containing macroprolactin for potential aetiologies.
Main Results:
- Macroprolactinaemia was diagnosed in 3.68% (49/1330) of subjects.
- Subjects with macroprolactinaemia exhibited a significantly higher frequency of hyperprolactinaemia (30.6%) compared to those without (2.26%).
- Prolactin-IgG complexes, primarily involving anti-prolactin autoantibodies, were identified as the major cause of macroprolactin, with glycosylation, aggregation, and binding also contributing.
Conclusions:
- Macroprolactinaemia is a prevalent condition in healthy populations, contributing to hyperprolactinaemia.
- The primary aetiology involves prolactin-IgG complexes, largely driven by anti-prolactin autoantibodies.
- Other minor complex prolactin species also play a role in macroprolactin formation.
Related Concept Videos
Parkinson Disease l: Introduction
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Hyperthyroidism II: Pathophysiology
Atypical Pneumonia
Cushing Syndrome II: Pathophysiology